Gary L. Shope Joins Patheon as Chief of Staff

RESEARCH TRIANGLE PARK, N.C., July 21, 2011 /PRNewswire/ - Patheon (TSX: PTI) announced today the appointment of Gary Shope to the newly created position of Chief of Staff, reporting to James C. Mullen, Patheon's Chief Executive Officer.  In this role, Gary will become an added resource on critical internal activities related to the company's strategy and its implementation, sites and other real estate, human resources and communications with key internal and external audiences.

"I first met Gary in 1992 when he was with the Research Triangle Foundation," said Mr. Mullen.  "I was impressed with his skills, insights and leadership.  His career has provided him with a wealth of experience in developing business relationships and coordinating the activities of many disparate entities for a common purpose and I look forward to the many contributions he will make in helping us profitably grow the organization."

Gary served as vice president of economic development for the Research Triangle Foundation for 16 years, the owner and developer of the Research Triangle Park.  Prior to his position with the Foundation, he was the Group Manager, Far East Group at the N.C. Department of Commerce.  Most recently, Gary was recruited to launch the Riyadh Technology Valley in Saudi Arabia, intended to bring together global corporations, international academic researchers and government leaders to promote the kingdom's technology potential.  Gary also worked with Orange County (N.C.) in developing more strategic positioning of the county for new and existing industry clusters and leveraging economic development partnerships with the university community.

Gary earned a Master of public administration from the University of North Carolina at Chapel Hill and he also holds an undergraduate degree from West Virginia Wesleyan College.

ABOUT PATHEON

Patheon is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry.  It provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi‐solid and liquid forms.  Its comprehensive range of fully integrated Pharmaceutical Development Services includes pre‐formulation, formulation, analytical development, clinical manufacturing, scale‐up and commercialization.  Its integrated development and manufacturing network of 10 facilities, eight development centers and one clinical trial packaging facility, across North America and Europe, ensures that customer products can be launched on‐time and with confidence anywhere in the world.

SOURCE Patheon Inc.